167 related articles for article (PubMed ID: 37806136)
1. Site-specific crosslinking reveals Phosphofructokinase-L inhibition drives self-assembly and attenuation of protein interactions.
Sivadas A; McDonald EF; Shuster SO; Davis CM; Plate L
Adv Biol Regul; 2023 Dec; 90():100987. PubMed ID: 37806136
[TBL] [Abstract][Full Text] [Related]
2. Site-Specific Crosslinking Reveals Phosphofructokinase-L Inhibition Drives Self-Assembly and Attenuation of Protein Interactions.
Sivadas A; McDonald EF; Shuster SO; Davis CM; Plate L
bioRxiv; 2023 Sep; ():. PubMed ID: 37781627
[TBL] [Abstract][Full Text] [Related]
3. Gene dosage and Down's syndrome: metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinase.
Elson A; Bernstein Y; Degani H; Levanon D; Ben-Hur H; Groner Y
Somat Cell Mol Genet; 1992 Mar; 18(2):143-61. PubMed ID: 1533471
[TBL] [Abstract][Full Text] [Related]
4. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
5. CITRATE INHIBITION OF PHOSPHOFRUCTOKINASE AND THE PASTEUR EFFECT.
SALAS ML; VINUELA E; SALAS M; SOLS A
Biochem Biophys Res Commun; 1965 Apr; 19():371-6. PubMed ID: 14317405
[No Abstract] [Full Text] [Related]
6. Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
Chen S; Wu Y; Gao Y; Wu C; Wang Y; Hou C; Ren M; Zhang S; Zhu Q; Zhang J; Yao Y; Huang M; Qi YB; Liu XS; Horng T; Wang H; Ye D; Zhu Z; Zhao S; Fan G
Cell Rep; 2023 Oct; 42(10):113246. PubMed ID: 37831605
[TBL] [Abstract][Full Text] [Related]
7. Altered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies.
Peled-Kamar M; Degani H; Bendel P; Margalit R; Groner Y
Brain Res; 1998 Nov; 810(1-2):138-45. PubMed ID: 9813288
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.
Elson A; Levanon D; Weiss Y; Groner Y
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):409-15. PubMed ID: 8172601
[TBL] [Abstract][Full Text] [Related]
9. The glycolytic enzyme phosphofructokinase-1 assembles into filaments.
Webb BA; Dosey AM; Wittmann T; Kollman JM; Barber DL
J Cell Biol; 2017 Aug; 216(8):2305-2313. PubMed ID: 28646105
[TBL] [Abstract][Full Text] [Related]
10. PROPERTIES OF PHOSPHOFRUCTOKINASE FROM RAT LIVER AND THEIR RELATION TO THE CONTROL OF GLYCOLYSIS AND GLUCONEOGENESIS.
UNDERWOOD AH; NEWSHOLME EA
Biochem J; 1965 Jun; 95(3):868-75. PubMed ID: 14342527
[TBL] [Abstract][Full Text] [Related]
11. miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
Li N; Wang X; Sun J; Liu Y; Han A; Lin Z; Yang Y
Carcinogenesis; 2022 Aug; 43(7):705-715. PubMed ID: 35511493
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C (PKC) level is increased in PC12 cells overexpressing transfected liver-type phosphofructokinase.
Elson A; Weiss Y; Groner Y
Biol Cell; 1994; 81(1):23-9. PubMed ID: 7987239
[TBL] [Abstract][Full Text] [Related]
13. Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.
Van Keuren M; Drabkin H; Hart I; Harker D; Patterson D; Vora S
Hum Genet; 1986 Sep; 74(1):34-40. PubMed ID: 2944814
[TBL] [Abstract][Full Text] [Related]
14. Construction of a cDNA clone containing the entire coding region of the human liver-type phosphofructokinase.
Levanon D; Danciger E; Dafni N; Groner Y
Biochem Biophys Res Commun; 1987 Sep; 147(3):1182-7. PubMed ID: 2822040
[TBL] [Abstract][Full Text] [Related]
15. Impaired glucose-induced insulin response in transgenic mice overexpressing the L-phosphofructokinase gene.
Knobler H; Weiss Y; Peled M; Groner Y
Diabetes; 1997 Sep; 46(9):1414-8. PubMed ID: 9287040
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma.
Zhang X; Geng L; Tang Y; Wang Y; Zhang Y; Zhu C; Lei H; Xu H; Zhu Q; Wu Y; Gu W
J Transl Med; 2024 Feb; 22(1):193. PubMed ID: 38388430
[TBL] [Abstract][Full Text] [Related]
17. PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer.
Yang J; Li J; Le Y; Zhou C; Zhang S; Gong Z
Am J Cancer Res; 2016; 6(2):473-85. PubMed ID: 27186417
[TBL] [Abstract][Full Text] [Related]
18. Regulation of phosphofructokinase in perfused rat heart. Requirement for fructose 2,6-bisphosphate and a covalent modification.
Narabayashi H; Lawson JW; Uyeda K
J Biol Chem; 1985 Aug; 260(17):9750-8. PubMed ID: 3160703
[TBL] [Abstract][Full Text] [Related]
19.
Zheng J; Luo J; Zeng H; Guo L; Shao G
Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
[TBL] [Abstract][Full Text] [Related]
20. TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation.
Li L; Li L; Li W; Chen T; Bin Zou ; Zhao L; Wang H; Wang X; Xu L; Liu X; Wang D; Li B; Mak TW; Du W; Yang X; Jiang P
Nat Commun; 2018 Nov; 9(1):4683. PubMed ID: 30409970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
